[1] Global status report on alcohol and health 2018. Geneva: World Health Organization,2018.
[2] Manthey J, Shield KD, Rylett M,, et al. Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study. Lancet, 2019, 393: 2493–502.
[3] Asrani SK, Mellinger J, Arab JP, et al. Reducing the Global Burden of Alcohol-Associated Liver Disease: A Blueprint for Action. Hepatology,2021,73(5):2039-2050.
[4] World Health Organization. World health statistics 2022: monitoring health for the SDGs, sustainable development goals. World Health Organization,2022.
[5] Xu H, Xiao P, Zhang F, et al. Epidemic characteristics of alcohol-related liver disease in Asia from 2000 to 2020: A systematic review and meta-analysis. Liver Int,2022, 42(9):1991-1998.
[6] Hagstr?m H, Thiele M, Roelstraete B, et al. Mortality in biopsy-proven alcohol-related liver disease: a population-based nationwide cohort study of 3453 patients. Gut,2021, 70(1):170-179.
[7] Hagstr?m H, Thiele M, Sharma R, et al. Risk of Cancer in Biopsy-Proven Alcohol-Related Liver Disease: A Population-Based Cohort Study of 3410 Persons. Clin Gastroenterol Hepatol,2022,20(4):918-929.
[8] Shaheen AA, Kong K, Ma C, et al. Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada. Clin Gastroenterol Hepatol,2022, 20(5):e1170-e1179.
[9] Sundaram V, Jalan R, Shah P, et al. Acute on Chronic Liver Failure From Nonalcoholic Fatty Liver Disease: A Growing and Aging Cohort With Rising Mortality. Hepatology,2021, 73(5):1932-1944.
[10] Gao X, Lv F, He X, et al. Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States. J Hepatol,2023,78(1):16-27.
[11] Julien J, Ayer T, Tapper EB, et al. Effect of increased alcohol consumption during COVID-19 pandemic on alcohol-associated liver disease: A modeling study. Hepatology,2022, 75(6):1480-1490.
[12] Effenberger M, Widjaja AA, Grabherr F, et al. Interleukin-11 drives human and mouse alcohol-related liver disease. Gut,2023,72(1):168-179.
[13] Martino C, Zaramela LS, Gao B, et al. Acetate reprograms gut microbiota during alcohol consumption. Nat Commun,2022,13(1):4630.
[14] Buch S, Innes H, Lutz PL, et al. Genetic variation in?TERT?modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study. Gut, 2023,72(2):381-391.
[15] Lackner C, Stauber RE, Davies S, et al. Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease. J Hepatol,2021, 75(4):810-819.
[16] Ventura-Cots M, Argemi J, Jones PD, et al. Clinical, histological and molecular profiling of different stages of alcohol-related liver disease. Gut,2022,71(9):1856-1866.
[17] Niu L, Thiele M, Geyer PE, et al. Noninvasive proteomic biomarkers for alcohol-related liver disease. Nat Med,2022 ,28(6):1277-1287.
[18] Whitfield JB, Schwantes-An TH, Darlay R, et al. A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers. J Hepatol,2022,76(2):275-282.
[19] Israelsen M, Juel HB, Detlefsen S, et al. Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver Fibrosis. Clin Gastroenterol Hepatol,2022 ,20(8):1784-1794.
[20] Wang Q, Kim SY, Matsushita H, et al. Oral administration of PEGylated TLR7 ligand ameliorates alcohol-associated liver disease via the induction of IL-22. Proc Natl Acad Sci U S A,2021,118(1):e2020868118.
[21] Musto J, Stanfield D, Ley D, et al. Recovery and outcomes of patients denied early liver transplantation for severe alcohol-associated hepatitis. Hepatology,2022,75(1):104-114.
[22] Louvet A, Labreuche J, Moreno C, et al. Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study. Lancet Gastroenterol Hepatol,2022,7(5):416-425.
[23] Arab JP, Izzy M, Leggio L, et al. Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation. Nat Rev Gastroenterol Hepatol, 2022, 19: 45-59.
[24] Singal AK, Kwo P, Kwong A, et al. Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease. Hepatology,2022,75(4):1026-1037. |
